• $237,195.00
    Market Cap
  • -99.64%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: 26
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

No data found

No data found

Peers

Statistics

More
Day Range
$0.0001
$0.0001
$0.0001
1-Year Range
$0.000001
$0.03
$0.0001
Latest Close$0.0001
Change
$0.00 (0.00%)
Volume41,112,696
Market Cap$237,195.00
Shares Outstanding2.4B
P/E (TTM)-0.009
Diluted EPS (TTM)-$0.01
Enterprise Value$4.1M

Information as of 07/31/2026

Company Profile

$237,195.00
Market Cap
-$3.8M
Net Income
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
4851 Tamiami Trail North, Naples, FL, United States, 34103
954 715 6000

Stemtech Corporation, a stem cell nutrition company, develops science-based products to help the body maintain healthy stem cell physiology in the Americas, Latin America, and Asia. The company's products enhance and support the work of the body's stem cells by releasing more stem cells, helping to circulate them in the blood, and migrate them into tissues, where they can perform their daily function of renewal for optimal health. It offers its products under the RCM System, stemrelease3, and Stemflo MigraStem brands; oral health care under the OraStem brand; and rapid renew stem cell peptide night cream under the Collect One brand name, as well as Cellect One shield hypochlorous acid skin care products. It sells products through independent distributors. Stemtech Corporation was founded in 2005 and is headquartered in Naples, Florida.

Key Executives

  • Charles S. Arnold
  • John W. Meyer
  • Shrilakshmi Vadlapatla
  • Lizette Leos
  • Tufan Obuz

Current Ownership Distribution

  • Other136.8M (93.58%)
  • Insiders9.4M (6.42%)
  • Institutions0 (0.00%)
  • Mutual Funds0 (0.00%)